Estrogen Receptor Positive Breast Cancer Active Not Recruiting Phase 2 Trials for Everolimus (DB01590)

Also known as: Oestrogen receptor positive breast cancer

DBCOND0049177 (Estrogen Receptor Positive Breast Cancer)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT02269670Phase II Study of Everolimus Beyond ProgressionTreatment
NCT02216786A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast CancerTreatment